Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm
Circulation Research · 24.05.2024 · 134 (11) · 1495-1511
DOI: 10.1161/circresaha.124.324323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 24.05.2024. Verfasst von Ying Wen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatrics (Y.W., Y. Liu, J.T., X.F., D.L., X.F., C.C., Y.Z., W.H.T.), Guangzhou Women and Children's Medical Centre, Guangzhou Medical …. Hauptthemen laut MEDLINE: Activating Transcription Factor 3, Aortic Aneurysm, Abdominal, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Abdominal aortic aneurysm (AAA) is a catastrophic disease with little effective therapy, likely due to the limited understanding of the mechanisms underlying AAA development and progression. ATF3 (activating transcription factor 3) has been increasingly recognized as a key regulator of cardiovascular diseases. However, the role of ATF3 in AAA development and progression remains elusive. METHODS: Genome-wide RNA sequencing analysis was performed on the aorta isolated from saline or Ang II (angiotensin II)–induced AAA mice, and ATF3 was identified as the potential key gene for AAA development. To examine the role of ATF3 in AAA development, vascular smooth muscle cell–specific ATF3 knockdown or overexpressed mice by recombinant adeno-associated virus serotype 9 vectors carrying ATF3, or shRNA-ATF3 with SM22α (smooth muscle protein 22-α) promoter were used in Ang II–induced AAA mice. In human and murine vascular smooth muscle cells, gain or loss of function experiments were performed to investigate the role of ATF3 in vascular smooth muscle cell proliferation and apoptosis. RESULTS: In both Ang II–induced AAA mice and patients with AAA, the expression of ATF3 was reduced in aneurysm tissues but increased in aortic lesion tissues. The deficiency of ATF3 in vascular smooth muscle cell promoted AAA formation in Ang II–induced AAA mice. PDGFRB (platelet-derived growth factor receptor β) was identified as the target of ATF3, which mediated vascular smooth muscle cell proliferation in response to TNF-alpha (tumor necrosis factor-α) at the early stage of AAA. ATF3 suppressed the mitochondria-dependent apoptosis at the advanced stage by upregulating its direct target BCL2. Our chromatin immunoprecipitation results also demonstrated that the recruitment of NFκB1 and P300/BAF/H3K27ac complex to the ATF3 promoter induces ATF3 transcription via enhancer activation. NFKB1 inhibitor (andrographolide) inhibits the expression of ATF3 by blocking the recruiters NFKB1 and ATF3-enhancer to the ATF3-promoter region, ultimately leading to AAA development. CONCLUSIONS: Our results demonstrate a previously unrecognized role of ATF3 in AAA development and progression, and ATF3 may serve as a novel therapeutic and prognostic marker for AAA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pediatrics (Y.W., Y. Liu, J.T., X.F., D.L., X.F., C.C., Y.Z., W.H.T.), Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, China.
- Department of Vascular Surgery (Q.L.), the Second Affiliated Hospital of Guangzhou Medical University, China.
- Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, China (Y. Liang).
- Department of Neurosurgery (Y.T.), the Second Affiliated Hospital of Guangzhou Medical University, China.
- Department of Organ Transplantation (L.L., Z.C.), the Second Affiliated Hospital of Guangzhou Medical University, China.
- Department of Occupational Health and Medicine, School of Public Health, Southern Medical University, China (X.Z.).
ORCID-Profile: Ying Wen, Yingying Liu, Xing Fu, Yiwen Liang, Chaofei Chen, Renjing Liu, Yuan Zhang, Wai Ho Tang
Zitieren
APA
Wen, Y., Liu, Y., Li, Q., Tan, J., Fu, X., Liang, Y., Tuo, Y., Liu, L., Zhou, X., LiuFu, D., Fan, X., Chen, C., Chen, Z., Wang, Z., Fan, S., Liu, R., Pan, L., Zhang, Y., & Tang, W. H. (2024). Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm. Circulation Research, 134(11), 1495-1511. https://doi.org/10.1161/circresaha.124.324323
Vancouver
Wen Y, Liu Y, Li Q, Tan J, Fu X, Liang Y, et al. Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm. Circulation Research. 2024;134(11):1495-1511. doi:10.1161/circresaha.124.324323
BibTeX
@article{Wen2024,
author = {Wen, Ying and Liu, Yingying and Li, Qiang and Tan, Jinlin and Fu, Xing and Liang, Yiwen and Tuo, Yonghua and Liu, Luhao and Zhou, Xueqiong and LiuFu, Dongkai and Fan, Xuejiao and Chen, Chaofei and Chen, Zheng and Wang, Zhouping and Fan, Shunyang and Liu, Renjing and Pan, Lei and Zhang, Yuan and Tang, Wai Ho},
title = {Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm},
journal = {Circulation Research},
year = {2024},
volume = {134},
number = {11},
pages = {1495--1511},
doi = {10.1161/circresaha.124.324323}
}
EUVIMED